Bios Equity COF, LP is Director & 10% Owner at ACTUATE THERAPEUTICS, INC. (ACTU). They have made 1 open-market trade across 1 company since 2025, most recently 2025-06-27.
CIK 0002000747
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
1 open-market purchase totalling $500K since 2025, never a sale. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ACTU | 196,428 | $117K |
Shares reported on the most recent Form 4, priced at the 2025-06-30 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ACTU | BUY | 2025-06-27 | 2025-06-30 | $7.00 | $500K | -3.8% | +13.9% | +6.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.